Journal
JOURNAL OF IMMUNOLOGY
Volume 184, Issue 11, Pages 6177-6187Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0904085
Keywords
-
Categories
Funding
- National Institutes of Health [RO1 AI023283, AI063026, AI065639, GM084361, CA06664]
- Irvington Institute, Cancer Research Institute
Ask authors/readers for more resources
Ig class switch recombination (CSR) occurs in activated mature B cells, and causes an exchange of the IgM isotype for IgG, IgE, or IgA isotypes, which increases the effectiveness of the humoral immune response. DNA ds breaks in recombining switch (S) regions, where CSR occurs, are required for recombination. Activation-induced cytidine deaminase initiates DNA ds break formation by deamination of cytosines in S regions. This reaction requires reactive oxygen species (ROS) intermediates, such as hydroxyl radicals. In this study we show that the ROS scavenger N-acetylcysteine inhibits CSR. We also demonstrate that IFN-gamma treatment, which is used to induce IgG2a switching, increases intracellular ROS levels, and activates p53 in switching B cells, and show that p53 inhibits IgG2a class switching through its antioxidant-regulating function. Finally, we show that p53 inhibits DNA breaks and mutations in S regions in B cells undergoing CSR, suggesting that p53 inhibits the activity of activation-induced cytidine deaminase. The Journal of Immunology, 2010, 184: 6177-6187.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available